2037 related articles for article (PubMed ID: 16468304)
1. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
2. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
[TBL] [Abstract][Full Text] [Related]
5. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
6. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.
Overmyer M; Helisalmi S; Soininen H; Laakso M; Riekkinen P; Alafuzoff I
Dement Geriatr Cogn Disord; 1999; 10(4):252-7. PubMed ID: 10364641
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
8. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
[TBL] [Abstract][Full Text] [Related]
10. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
11. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of preclinical Alzheimer's disease pathology and its modulation by ApoE genotype.
Pletnikova O; Kageyama Y; Rudow G; LaClair KD; Albert M; Crain BJ; Tian J; Fowler D; Troncoso JC
Neurobiol Aging; 2018 Nov; 71():72-80. PubMed ID: 30099348
[TBL] [Abstract][Full Text] [Related]
13. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
14. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
15. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
[TBL] [Abstract][Full Text] [Related]
18. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
19. A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.
Hesse C; Bogdanovic N; Davidsson P; Blennow K
Dement Geriatr Cogn Disord; 1999; 10(6):452-9. PubMed ID: 10559559
[TBL] [Abstract][Full Text] [Related]
20. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
